National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation

This study tests whether a combination of three heart medications (SGLT2 inhibitor, ARNI, and MRA) can improve heart structure, function, and daily life in people with advanced heart failure with preserved ejection fraction (HFpEF). Fifty participants will receive either the trip…

This study tests a treatment for people with a dangerous blood clot in the lungs (pulmonary embolism). The approach uses a thin tube guided by ultrasound to deliver clot-busting medicine directly to the clot, aiming to reduce death and serious bleeding. About 300 adults with mode…

This study tests a temporary heart pump called iVAC 2L in 100 people with severe coronary artery disease who need high-risk angioplasty. The pump helps the heart keep pumping blood during the procedure. Researchers will track deaths, heart attacks, and strokes for one year to see…

This study follows 500 people with a type of heart failure called HFpEF over at least 3 years. Researchers want to find out which medical tests or body signals best predict serious problems like hospitalization or death. Participants had detailed heart exams, including exercise t…

This study will collect information from 20,000 people with chronic heart failure in Russia to understand how they are diagnosed, treated, and monitored. Researchers will look at which medicines are used and how patients are doing. The goal is to find ways to improve heart failur…

This study follows 2,000 people with chronic coronary artery disease who take long-term blood thinners. Researchers track how many have heart attacks, strokes, or serious bleeding. The goal is to better understand the balance of risks and benefits, not to test a new treatment.

This study is creating a registry of over 10,000 people with high blood pressure. Researchers will analyze medical records and treatments to see how well current guidelines are being followed and find ways to improve care. The goal is to develop more personalized treatment approa…

This study is a registry that will follow 2000 people with atrial fibrillation (an irregular heartbeat) who are taking long-term blood thinners. The goal is to track how often serious bleeding or heart problems like stroke or heart attack occur. Researchers hope to better underst…